Intelligence

#Drug discovery

Case Study – A Free Energy Perturbation (FEP) study: Identifying ‘new’, active ligands for TYK2

In this case study, we test the predictive abilities of Free Energy Perturbation (FEP) to arrive at accurate binding free energies for ‘new’ ligand suggestions within the TYK2 system.   Computational methods used include: Molecular Dynamics (MD) Water analysis solving the Ornstein-Zernike equation (3D-RISM) Alignment of ligands for FEP (Conformation… Read More

#Case Studies

Business financing
#Artificial intelligence (AI) #Drug development #Drug discovery #Financing

Tres Alchemix closes $4.4 million financing round

AI-driven biotechnology company Tres Alchemix has closed its $4.4 million Series A financing round, the company has announced.  New funding will be used to accelerate the development of Tres Alchemix’s predictive AI platform and support the opening of a new laboratory at The Oxford Science Park, a… Read More

#Business & Investment #News #Start-up Zone

European biotech
#Biologics / Biotechnology #Biotech #Europe #European Commission #European Union

Is the European Biotech Act a one-shot solution for the biotech sector?

For European Biotech Week, Diana Turner and Dr Claire Skentelbery, Director General, EuropaBio, examine the potential impact of the European Biotech Act. The European Biotech Act was first introduced by Ursula von der Leyen in 2024 in her paper ‘Europe’s Choice: Political Guidelines For The Next… Read More

#Exclusive Content #Trends & Analysis

#Neuroscience

Whitepaper – Navigating Neurological Biomarker Research: Progress, Learnings and Future Directions

Neurological biomarker research is advancing rapidly, but key challenges remain. This whitepaper captures: Expert perspectives from academia and biopharma Highlighting successes, setbacks, and strategies for translational advancements in Alzheimer’s, Parkinson’s, and MS. A must-read for researchers navigating the future of precision neurology.   Brought to… Read More

#Whitepapers

eBook: The impact of ADCs on drug discovery
#Antibody drug conjugate (ADC) #Drug discovery #eBook #Therapeutic Antibodies

The impact of ADCs on drug discovery

This eBook, sponsored by Abzena, explores the latest developments in the ADC field and the opportunities presented by next generation bioconjugates.

#DDW eBooks #Intelligence

#Cancer research #Drug discovery

Ebook: The impact of ADCs on drug discovery

Antibody-drug conjugates (ADCs) offer a targeted approach to cancer treatment, combining the specificity of antibodies with the potency of cytotoxic drugs, and have shown promise in improving patient outcomes. This eBook, sponsored by Abzena, explores the latest developments in the ADC field and the opportunities presented by next generation bioconjugates. Read More

#DDW eBooks

#Cell Science #Drug discovery

Ebook: Unlocking the power of regenerative medicine

The term “regenerative medicine” is used to refer to methods to replace or regenerate human cells, tissues or organs to restore or establish normal function. This eBook, sponsored by ThinkCyte, examines the latest advances in the sector and the market potential for regenerative medicine. Download this exclusive eBook to… Read More

#DDW eBooks

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Guide #Machine learning

How AI is transforming drug discovery

‘How AI is transforming drug discovery’ is an exclusive Guide published by DDW that examines the challenges and opportunities this technology is presenting throughout the industry. Read More

#DDW eBooks #DDW Guides

#Drug discovery #Multi-omics #Omics #Whitepaper

Accelerating pharma innovation and drug discovery with 5D multiomics

Today’s drug discovery teams face increasing pressure to accelerate timelines, improve translational success, and minimise costly clinical failures. Yet most platforms still rely on fragmented technologies that deliver partial or delayed insights—forcing you to reconstruct biology from disconnected data. AVITI24™ 5D multiomics platform offers a new path by capturing RNA,… Read More

#Resources

#AAV #Gene sequencing #Gene therapy #Nanopore sequencing

A complete workflow for full-length AAV sequencing

Ensuring the integrity of adeno-associated virus (AAV) vectors is critical for gene therapy success, yet traditional methods can miss key structural elements. Discover how nanopore sequencing enables comprehensive characterisation of AAV genomes — including inverted terminal repeats (ITRs), transgenes, and promoters — all in a single workflow. Download this workflow… Read More

#Resources

#Artificial intelligence (AI)

Guide: How AI is transforming drug discovery

“How AI is transforming drug discovery” is an exclusive guide published by DDW that examines the challenges and opportunities this technology is presenting throughout the industry.   It features stories on how AI is shaping drug discovery, how RNA-targeted drug discovery is being pioneered by AI and how the technology… Read More

#DDW Guides

#Biomarkers #Oncology #Whitepaper

Learn about protein biomarkers shaping cancer outcomes in the tumour microenvironment

The tumour microenvironment (TME) is no longer considered a passive backdrop to cancer. It is a dynamic ecosystem that plays a central role in tumour growth, immune suppression, metastasis and treatment resistance. Whitepaper highlights: Understand how the TME drives cancer progression, immune evasion and therapeutic resistance Explore emerging strategies that… Read More

#Resources